Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,968 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma.
Roeder F, Schulz-Ertner D, Nikoghosyan AV, Huber PE, Edler L, Habl G, Krempien R, Oertel S, Saleh-Ebrahimi L, Hensley FW, Buechler MW, Debus J, Koch M, Weitz J, Bischof M. Roeder F, et al. Among authors: koch m. BMC Cancer. 2012 Jul 12;12:287. doi: 10.1186/1471-2407-12-287. BMC Cancer. 2012. PMID: 22788989 Free PMC article. Clinical Trial.
Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer.
Timke C, Winnenthal HS, Klug F, Roeder FF, Bonertz A, Reissfelder C, Rochet N, Koch M, Tjaden C, Buechler MW, Debus J, Werner J, Beckhove P, Weitz J, Huber PE. Timke C, et al. Among authors: koch m. BMC Cancer. 2011 Apr 13;11:134. doi: 10.1186/1471-2407-11-134. BMC Cancer. 2011. PMID: 21489291 Free PMC article. Clinical Trial.
A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer.
Reissfelder C, Timke C, Schmitz-Winnenthal H, Rahbari NN, Koch M, Klug F, Roeder F, Edler L, Debus J, Büchler MW, Beckhove P, Huber PE, Weitz J. Reissfelder C, et al. Among authors: koch m. BMC Cancer. 2011 Sep 30;11:419. doi: 10.1186/1471-2407-11-419. BMC Cancer. 2011. PMID: 21961577 Free PMC article. Clinical Trial.
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
Halama N, Zoernig I, Berthel A, Kahlert C, Klupp F, Suarez-Carmona M, Suetterlin T, Brand K, Krauss J, Lasitschka F, Lerchl T, Luckner-Minden C, Ulrich A, Koch M, Weitz J, Schneider M, Buechler MW, Zitvogel L, Herrmann T, Benner A, Kunz C, Luecke S, Springfeld C, Grabe N, Falk CS, Jaeger D. Halama N, et al. Among authors: koch m. Cancer Cell. 2016 Apr 11;29(4):587-601. doi: 10.1016/j.ccell.2016.03.005. Cancer Cell. 2016. PMID: 27070705 Free article.
Potential target antigens for immunotherapy in human pancreatic cancer.
Schmitz-Winnenthal FH, Galindo-Escobedo LV, Rimoldi D, Geng W, Romero P, Koch M, Weitz J, Krempien R, Niethammer AG, Beckhove P, Buchler MW, Z'graggen K. Schmitz-Winnenthal FH, et al. Among authors: koch m. Cancer Lett. 2007 Jul 18;252(2):290-8. doi: 10.1016/j.canlet.2007.01.003. Epub 2007 Feb 22. Cancer Lett. 2007. PMID: 17320278
Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination - prospective randomized multicenter trial.
Schmidt T, Koch M, Antolovic D, Reissfelder C, Schmitz-Winnenthal FH, Rahbari NN, Schmidt J, Seiler CM, Büchler MW, Weitz J. Schmidt T, et al. Among authors: koch m. BMC Surg. 2008 Mar 5;8:6. doi: 10.1186/1471-2482-8-6. BMC Surg. 2008. PMID: 18321372 Free PMC article. Clinical Trial.
3,968 results